| 1 |
Clinical values of expression signature of circCDR1AS and circHIAT1 in prostate cancer: Two circRNAs with regulatory function in androgen receptor (AR) and PI3K/AKT signaling pathways |
|
|
| Mahsa Aghajani Mir, Hossein Dinmohammadi, Emadoddin Moudi, Nima Motamed, Abdolreza Daraei |
|
| Journal of Clinical Laboratory Analysis. 2022; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 2 |
The genes controlling normal function of citrate and spermine secretion are lost in aggressive prostate cancer and prostate model systems |
|
|
| Morten Beck Rye, Sebastian Krossa, Martina Hall, Casper van Mourik, Tone F. Bathen, Finn Drabløs, May-Britt Tessem, Helena Bertilsson |
|
| iScience. 2022; 25(6): 104451 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 3 |
GNE-493 inhibits prostate cancer cell growth via Akt-mTOR-dependent and -independent mechanisms |
|
|
| Lu Jin, Wei Zhang, Ming-Yu Yao, Ye Tian, Bo-xin Xue, Wei Tao |
|
| Cell Death Discovery. 2022; 8(1) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 4 |
The androgen receptor is a therapeutic target in desmoplastic small round cell sarcoma |
|
|
| Salah-Eddine Lamhamedi-Cherradi, Mayinuer Maitituoheti, Brian A. Menegaz, Sandhya Krishnan, Amelia M. Vetter, Pamela Camacho, Chia-Chin Wu, Hannah C. Beird, Robert W. Porter, Davis R. Ingram, Vandhana Ramamoorthy, Sana Mohiuddin, David McCall, Danh D. Truong, Branko Cuglievan, P. Andrew Futreal, Alejandra Ruiz Velasco, Nazanin Esmaeili Anvar, Budi Utama, Mark Titus, Alexander J. Lazar, Wei-Lien Wang, Cristian Rodriguez-Aguayo, Ravin Ratan, J. Andrew Livingston, Kunal Rai, A. Robert MacLeod, Najat C. Daw, Andrea Hayes-Jordan, Joseph A. Ludwig |
|
| Nature Communications. 2022; 13(1) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 5 |
Driver gene detection through Bayesian network integration of mutation and expression profiles |
|
|
| Zhong Chen, You Lu, Bo Cao, Wensheng Zhang, Andrea Edwards, Kun Zhang, Pier Luigi Martelli |
|
| Bioinformatics. 2022; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 6 |
Solamargine Inhibits Prostate Cancer Cell Growth and Enhances the Therapeutic Efficacy of Docetaxel via Akt Signaling |
|
|
| Jianchao Ge, Pengyu Wang, Hangbin Ma, Jun Zhang, Sakthivel Muniyan |
|
| Journal of Oncology. 2022; 2022: 1 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 7 |
The Extracellular Matrix Stiffening: A Trigger of Prostate Cancer Progression and Castration Resistance? |
|
|
| Carole Luthold, Tarek Hallal, David P. Labbé, François Bordeleau |
|
| Cancers. 2022; 14(12): 2887 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 8 |
The Integration of Metabolomics with Other Omics: Insights into Understanding Prostate Cancer |
|
|
| Eleazer P. Resurreccion, Ka-wing Fong |
|
| Metabolites. 2022; 12(6): 488 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 9 |
Role of PI3K-AKT-mTOR Pathway as a Pro-Survival Signaling and Resistance-Mediating Mechanism to Therapy of Prostate Cancer |
|
|
| Thanakorn Pungsrinont, Julia Kallenbach, Aria Baniahmad |
|
| International Journal of Molecular Sciences. 2021; 22(20): 11088 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 10 |
Diosmetin Induces Modulation of Igf-1 and Il-6 Levels to Al-Ter Rictor-Akt-PKCa Cascade in Inhibition of Prostate Cancer |
|
|
| Rebecca Pakradooni,Nishka Shukla,Kalpana Gupta,Jatinder Kumar,Ilaha Isali,Ahmed O. Khalifa,Sanjeev Shukla |
|
| Journal of Clinical Medicine. 2021; 10(20): 4741 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 11 |
Signaling Pathways That Control Apoptosis in Prostate Cancer |
|
|
| Amaal Ali,George Kulik |
|
| Cancers. 2021; 13(5): 937 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 12 |
ELOVL5-Mediated Long Chain Fatty Acid Elongation Contributes to Enzalutamide Resistance of Prostate Cancer |
|
|
| Huan Xu,Sangsang Li,Yi Sun,Lingfan Xu,Xin Hong,Zhong Wang,Hailiang Hu |
|
| Cancers. 2021; 13(16): 3957 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 13 |
A Systems Approach to Interrogate Gene Expression Patterns in African American Men Presenting with Clinically Localized Prostate Cancer |
|
|
| Gary Hardiman,Stephen J. Savage,E. Starr Hazard,Willian A. da Silveira,Rebecca Morgan,Adam Harris,Melanie S. Jefferson,Robert C. Wilson,Susan Caulder,Linda Ambrose,Lewis Frey,Bethany Wolf,Sebastiano Gattoni-Celli,Chanita Hughes Halbert |
|
| Cancers. 2021; 13(20): 5143 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 14 |
Efficient Everolimus Treatment for Metastatic Castration Resistant Prostate Cancer with AKT1 Mutation: A Case Report |
|
|
| Zhe Yu, Wei Wei, Hongruo Liu, Evenki Pan, Peng Yang, Kui Jiang |
|
| OncoTargets and Therapy. 2021; Volume 14: 5423 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 15 |
The role of opiorphin genes in prostate cancer growth and progression |
|
|
| Amarnath Mukherjee,Augene Park,Li Wang,Kelvin P Davies |
|
| Future Oncology. 2021; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 16 |
Five Circular RNAs in Metabolism Pathways Related to Prostate Cancer |
|
|
| Lili Zhang,Wei Zhang,Hexin Li,Xiaokun Tang,Siyuan Xu,Meng Wu,Li Wan,Fei Su,Yaqun Zhang |
|
| Frontiers in Genetics. 2021; 12 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 17 |
Establishment of Novel Prostate Cancer Risk Subtypes and A Twelve-Gene Prognostic Model |
|
|
| Enchong Zhang,Fujisawa Shiori,Mo Zhang,Peng Wang,Jieqian He,Yuntian Ge,Yongsheng Song,Liping Shan |
|
| Frontiers in Molecular Biosciences. 2021; 8 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 18 |
Lifetime Impact of Cow’s Milk on Overactivation of mTORC1: From Fetal to Childhood Overgrowth, Acne, Diabetes, Cancers, and Neurodegeneration |
|
|
| Bodo C. Melnik |
|
| Biomolecules. 2021; 11(3): 404 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 19 |
Exploring the Value of BRD9 as a Biomarker, Therapeutic Target and Co-Target in Prostate Cancer |
|
|
| Nafisa Barma, Timothy C. Stone, Lina Maria Carmona Echeverria, Susan Heavey |
|
| Biomolecules. 2021; 11(12): 1794 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 20 |
Phase Ib study of patients with metastatic castrate-resistant prostate cancer treated with different sequencing regimens of atezolizumab and sipuleucel-T |
|
|
| Tanya Dorff,Yosuke Hirasawa,Jared Acoba,Ian Pagano,David Tamura,Sumanta Pal,Minlu Zhang,Rebecca Waitz,Abhilash Dhal,Winston Haynes,John Shon,Mark Scholz,Hideki Furuya,Owen T M Chan,Jeffrey Huang,Charles Rosser |
|
| Journal for ImmunoTherapy of Cancer. 2021; 9(8): e002931 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 21 |
Role of Episamarcandin in Promoting the Apoptosis of Human Colon Cancer HCT116 Cells through the PI3K-Akt Signaling Pathway |
|
|
| Haiying Zhang, Jianan Sun, Ruoting Ma, Shengjun Zhao, Shao-Hsuan Kao |
|
| Evidence-Based Complementary and Alternative Medicine. 2021; 2021: 1 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 22 |
Should androgen deprivation therapy and other systemic treatments be used in men with prostate cancer and a rising PSA post-local treatments? |
|
|
| Anna Patrikidou, Thomas Zilli, Giulia Baciarello, Safae Terisse, Zineb Hamilou, Karim Fizazi |
|
| Therapeutic Advances in Medical Oncology. 2021; 13: 1758835921 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 23 |
Distinct roles for the RNA-binding protein Staufen1 in prostate cancer |
|
|
| Kristen A. Marcellus,Tara E. Crawford Parks,Shekoufeh Almasi,Bernard J. Jasmin |
|
| BMC Cancer. 2021; 21(1) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 24 |
ENHANCED ANTICANCER POTENCY OF GEMCITABINE IN COMBINATION WITH PROPOFOL IN PROSTATE CANCER |
|
|
| Elanur AYDIN KARATAS,Kübra BAYINDIRLI |
|
| Hacettepe Journal of Biology and Chemistry. 2021; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 25 |
miR-92a promotes proliferation and inhibits apoptosis of prostate cancer cells through the PTEN/Akt signaling pathway |
|
|
| Zheng Yanshen,Yang Lifen,Wu Xilian,Dong Zhong,Mai Huihong |
|
| Libyan Journal of Medicine. 2021; 16(1): 1971837 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 26 |
Selective obstruction of the mTORC2 complex by a naturally occurring cholestane saponin (OSW-1) for inhibiting prostate cancer cell growth |
|
|
| Ahmed Elgehama |
|
| Journal of Asian Natural Products Research. 2021; : 1 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 27 |
Spirogyra neglecta (Hassall) Kützing attenuates metastasis of castration-resistant human prostate cancer via the blockage of AKT signaling pathway |
|
|
| Punnida Arjsri,Jutarop Phetcharaburanin,Manida Suksawat,Sariya Mapoung,Chayaporn Subkamkaew,Warathit Semmarath,Supachai Yodkeeree,Pornngarm Limtrakul (Dejkriengkraikul) |
|
| South African Journal of Botany. 2021; 139: 26 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 28 |
Prostate-specific Membrane Antigen Biology in Lethal Prostate Cancer and its Therapeutic Implications |
|
|
| Beshara Sheehan,Christina Guo,Antje Neeb,Alec Paschalis,Shahneen Sandhu,Johann S. de Bono |
|
| European Urology Focus. 2021; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 29 |
Clinical and genomic features of
SPOP
-mutant prostate cancer
|
|
|
| Mari Nakazawa, Mike Fang, Catherine H. Marshall, Tamara L. Lotan, Pedro Isaacsson Velho, Emmanuel S. Antonarakis |
|
| The Prostate. 2021; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 30 |
Roles of circRNAs in prostate cancer: expression, mechanism, application and potential |
|
|
| Chunlei Zhang,Qi Yang,Weiping Li,Yindong Kang,Fenghai Zhou,Dehui Chang |
|
| The International Journal of Biochemistry & Cell Biology. 2021; : 105968 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 31 |
Exosomes derived from PC-3 cells suppress osteoclast differentiation by downregulating miR-148a and blocking the PI3K/AKT/mTOR pathway |
|
|
| Gaoqiang Tian,Konghe Hu,Sujun Qiu,Yingming Xie,Yanlin Cao,Songjia Ni,Lifang Zhang |
|
| Experimental and Therapeutic Medicine. 2021; 22(5) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 32 |
MicroRNA-149 inhibits cancer cell malignant phenotype by regulating Akt1 in C4-2 CRPC cell line |
|
|
| Jiahui Zhao, Qiankun Li, Bingfu Feng, Dechao Wei, Yili Han, Mingchuan Li, Yongxing Wang, Yong Luo, Yongguang Jiang |
|
| Oncology Reports. 2021; 46(6) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 33 |
TNFAIP8 drives metabolic reprogramming to promote prostate cancer cell proliferation |
|
|
| Suryakant Niture,Minghui Lin,Joab O. Odera,John Moore,Hong Zhe,Xiaoxin Chen,Simeng Suy,Sean P. Collins,Deepak Kumar |
|
| The International Journal of Biochemistry & Cell Biology. 2020; : 105885 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 34 |
Fetuin B overexpression suppresses proliferation, migration, and invasion in prostate cancer by inhibiting the PI3K/AKT signaling pathway |
|
|
| Kai Zhan,Rui Liu,Hang Tong,Shun Gao,Guang Yang,Arman Hossain,Tinghao Li,Weiyang He |
|
| Biomedicine & Pharmacotherapy. 2020; 131: 110689 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 35 |
SNX-2112, an Hsp90 inhibitor, suppresses cervical cancer cells proliferation, migration, and invasion by inhibiting the Akt/mTOR signaling pathway |
|
|
| Liang-Shun Fu,Hong-Hong Qiu,Min Liu,Liu-Bing Hu,Yan Wang,Peng-Chao Zhang,Man-Mei Li,Yi-Fei Wang,Zhong Liu |
|
| Medicinal Chemistry Research. 2020; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 36 |
CD133 suppression increases the sensitivity of prostate cancer cells to paclitaxel |
|
|
| Marjan Aghajani,Ahad Mokhtarzadeh,Leili Aghebati-Maleki,Behzad Mansoori,Ali Mohammadi,Sahar Safaei,Zahra Asadzadeh,Khalil Hajiasgharzadeh,Vahid Khaze Shahgoli,Behzad Baradaran |
|
| Molecular Biology Reports. 2020; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 37 |
Exendin-4 enhances the sensitivity of prostate cancer to enzalutamide by targeting Akt activation |
|
|
| He Wenjing,Yuanyuan Shao,Yi Yu,Wei Huang,Guoliang Feng,Junhe Li |
|
| The Prostate. 2020; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 38 |
Novel Nanococktail of a Dual PI3K/mTOR Inhibitor and Cabazitaxel for Castration-Resistant Prostate Cancer |
|
|
| Yee Huang,Xiangdong Xue,Xiaocen Li,Bei Jia,Chong-Xian Pan,Yuanpei Li,Tzu-Yin Lin |
|
| Advanced Therapeutics. 2020; : 2000075 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 39 |
Cellular growth factors as prospective therapeutic targets for combination therapy in androgen independent prostate cancer (AIPC) |
|
|
| Bhavana Jonnalagadda,Sumathy Arockiasamy,Sriram Krishnamoorthy |
|
| Life Sciences. 2020; : 118208 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 40 |
Isorhamnetin inhibited the proliferation and metastasis of androgen-independent prostate cancer cells by targeting the mitochondrion-dependent intrinsic apoptotic and PI3K/Akt/mTOR pathway |
|
|
| Fangzhen Cai,Yanmei Zhang,Jianwei Li,Sihuai Huang,Ruilin Gao |
|
| Bioscience Reports. 2020; 40(3) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 41 |
Co-targeting PIM and PI3K/mTOR using multikinase inhibitor AUM302 and a combination of AZD-1208 and BEZ235 in prostate cancer |
|
|
| Sabina Luszczak,Benjamin S. Simpson,Urszula Stopka-Farooqui,Vignesh Krishna Sathyadevan,Lina M. Carmona Echeverria,Christopher Kumar,Helena Costa,Aiman Haider,Alex Freeman,Charles Jameson,Marzena Ratynska,Imen Ben-Salha,Ashwin Sridhar,Greg Shaw,John D. Kelly,Hayley Pye,Kathy A. Gately,Hayley C. Whitaker,Susan Heavey |
|
| Scientific Reports. 2020; 10(1) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 42 |
Downregulation of lncRNA ZEB1-AS1 Represses Cell Proliferation, Migration, and Invasion Through Mediating PI3K/AKT/mTOR Signaling by miR-342-3p/CUL4B Axis in Prostate Cancer |
|
|
| Teng Ma,Hua Chen,Peilong Wang,Ningqiang Yang,Junsheng Bao |
|
| Cancer Biotherapy and Radiopharmaceuticals. 2020; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 43 |
Effect of the versatile bifunctional chelator AAZTA5 on the radiometal labelling properties and the in vitro performance of a gastrin releasing peptide receptor antagonist |
|
|
| Michael Hofstetter,Euy Sung Moon,Fabio D’Angelo,Lucien Geissbühler,Ian Alberts,Ali Afshar-Oromieh,Frank Rösch,Axel Rominger,Eleni Gourni |
|
| EJNMMI Radiopharmacy and Chemistry. 2020; 5(1) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 44 |
Clinical, Cellular, and Molecular Evidence of the Additive Antitumor Effects of Biguanides and Statins in Prostate Cancer |
|
|
| Juan M Jiménez-Vacas,Vicente Herrero-Aguayo,Antonio J Montero-Hidalgo,Prudencio Sáez-Martínez,Enrique Gómez-Gómez,Antonio J León-González,Antonio C Fuentes-Fayos,Elena M Yubero-Serrano,María J Requena-Tapia,Miguel López,Justo P Castaño,Manuel D Gahete,Raúl M Luque |
|
| The Journal of Clinical Endocrinology & Metabolism. 2020; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 45 |
Fusion transcript detection using spatial transcriptomics |
|
|
| Stefanie Friedrich,Erik L. L. Sonnhammer |
|
| BMC Medical Genomics. 2020; 13(1) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 46 |
Synthetic Lethal Metabolic Targeting of Androgen-Deprived Prostate Cancer Cells with Metformin |
|
|
| Bing Yang,Shivashankar Damodaran,Tariq A. Khemees,Mikolaj J. Filon,Adam Schultz,Joseph Gawdzik,Tyler Etheridge,Dmitry Malin,Kyle A. Richards,Vincent L. Cryns,David F. Jarrard |
|
| Molecular Cancer Therapeutics. 2020; 19(11): 2278 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 47 |
Astragaloside IV enhanced carboplatin sensitivity in prostate cancer by suppressing AKT/NF-?B signaling pathway |
|
|
| Yi He,Qimei Zhang,Huan Chen,Qingxi Guo,Liming Zhang,Zhuo Zhang,Yingchuan Li |
|
| Biochemistry and Cell Biology. 2020; : 1 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 48 |
RNA-binding protein Musashi2 stabilizing androgen receptor drives prostate cancer progression |
|
|
| Jing Zhao,Yu Zhang,Xi-sheng Liu,Fang-ming Zhu,Feng Xie,Chen-yi Jiang,Zi-ye Zhang,Ying-li Gao,Yong-chuan Wang,Bin Li,Shu-jie Xia,Bang-min Han |
|
| Cancer Science. 2020; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 49 |
Hierarchical Micro-Nano Topography Promotes Cell Adhesion and Osteogenic Differentiation via Integrin a2-PI3K-AKT Signaling Axis |
|
|
| Huimin Zheng,Yujuan Tian,Qian Gao,Yingjie Yu,Xianyou Xia,Zhipeng Feng,Feng Dong,Xudong Wu,Lei Sui |
|
| Frontiers in Bioengineering and Biotechnology. 2020; 8 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 50 |
Piceatannol Suppresses the Proliferation and Induced Apoptosis of Osteosarcoma Cells Through PI3K/AKT/mTOR Pathway |
|
|
| Bin Wang,Jingyu Li |
|
| Cancer Management and Research. 2020; Volume 12: 2631 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 51 |
Mechanisms of Androgen Receptor Agonist- and Antagonist-Mediated Cellular Senescence in Prostate Cancer |
|
|
| Miriam Kokal,Kimia Mirzakhani,Thanakorn Pungsrinont,Aria Baniahmad |
|
| Cancers. 2020; 12(7): 1833 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 52 |
Modulation of de Novo Lipogenesis Improves Response to Enzalutamide Treatment in Prostate Cancer |
|
|
| Mohamed Amine Lounis,Benjamin Péant,Kim Leclerc-Desaulniers,Dwaipayan Ganguli,Caroline Daneault,Matthieu Ruiz,Amina Zoubeidi,Anne-Marie Mes-Masson,Fred Saad |
|
| Cancers. 2020; 12(11): 3339 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 53 |
Natural Compounds in Prostate Cancer Prevention and Treatment: Mechanisms of Action and Molecular Targets |
|
|
| Fabrizio Fontana,Michela Raimondi,Monica Marzagalli,Alessandro Di Domizio,Patrizia Limonta |
|
| Cells. 2020; 9(2): 460 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 54 |
Increased ABCC4 Expression Induced by ERRa Leads to Docetaxel Resistance via Efflux of Docetaxel in Prostate Cancer |
|
|
| Houbao Huang,Jing Li,Jing Shen,Ling Lin,Xu Wu,Shixin Xiang,Yawei Li,Yujie Xu,Qijie Zhao,Yueshui Zhao,Parham Jabbarzadeh Kaboli,Mingxing Li,Xiang Li,Weiping Wang,Qinglian Wen,Zhangang Xiao |
|
| Frontiers in Oncology. 2020; 10 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 55 |
The PI3K-AKT-mTOR Pathway and Prostate Cancer: At the Crossroads of AR, MAPK, and WNT Signaling |
|
|
| Boris Y. Shorning,Manisha S. Dass,Matthew J. Smalley,Helen B. Pearson |
|
| International Journal of Molecular Sciences. 2020; 21(12): 4507 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 56 |
PI3K/ Akt/ mTOR Pathway as a Therapeutic Target for Colorectal Cancer: A Review of Preclinical and Clinical Evidence |
|
|
| Arunaksharan Narayanankutty |
|
| Current Drug Targets. 2019; 20(12): 1217 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 57 |
The Secret Life of Translation Initiation in Prostate Cancer |
|
|
| Greco Hernández,Jorge L. Ramírez,Abraham Pedroza-Torres,Luis A. Herrera,Miguel A. Jiménez-Ríos |
|
| Frontiers in Genetics. 2019; 10 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 58 |
pathfindR: An R Package for Comprehensive Identification of Enriched Pathways in Omics Data Through Active Subnetworks |
|
|
| Ege Ulgen,Ozan Ozisik,Osman Ugur Sezerman |
|
| Frontiers in Genetics. 2019; 10 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 59 |
Therapies Targeted to Androgen Receptor Signaling Axis in Prostate Cancer: Progress, Challenges, and Hope |
|
|
| Sirin Saranyutanon,Sanjeev Kumar Srivastava,Sachin Pai,Seema Singh,Ajay Pratap Singh |
|
| Cancers. 2019; 12(1): 51 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 60 |
Dairy Products: Is There an Impact on Promotion of Prostate Cancer? A Review of the Literature |
|
|
| Alexandra Vasconcelos,Teresa Santos,Paula Ravasco,Pedro Miguel Neves |
|
| Frontiers in Nutrition. 2019; 6 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 61 |
Intratumoral Heterogeneity Determines the Expression of mTOR-pathway Proteins in Prostate Cancer |
|
|
| Giorgio Ivan Russo,Jörg Hennenlotter,Ulrich Vogel,Ursula Kühs,Thomas Manfred Wurm,Valentina Gerber,Tim Neumann,Sebastiano Cimino,Arnulf Stenzl,Tilman Todenhöfer |
|
| Disease Markers. 2019; 2019: 1 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 62 |
Effect of Sulfated Polysaccharide from Undaria pinnatifida (SPUP) on Proliferation, Migration, and Apoptosis of Human Prostatic Cancer |
|
|
| Xiaolin Xu,Xin Zhu,Wenglong Lu,Yandong He,Yihan Wang,Feng Liu |
|
| International Journal of Polymer Science. 2019; 2019: 1 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 63 |
Gene Expression Studies to Identify Significant Genes in AR, MTOR, MAPK Pathways and their Overlapping Regulatory Role in Prostate Cancer |
|
|
| Nimisha Asati,Abhinav Mishra,Ankita Shukla,Tiratha Raj Singh |
|
| Journal of Integrative Bioinformatics. 2019; 0(0) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 64 |
MIIP inhibits the growth of prostate cancer via interaction with PP1a and negative modulation of AKT signaling |
|
|
| Guang Yan,Yi Ru,Fengqi Yan,Xin Xiong,Wei Hu,Tao Pan,Jianming Sun,Chi Zhang,Qinghao Wang,Xia Li |
|
| Cell Communication and Signaling. 2019; 17(1) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 65 |
MYSM1-AR complex-mediated repression of Akt/c-Raf/GSK-3ß signaling impedes castration-resistant prostate cancer growth |
|
|
| Jinbo Sun,Xiangnan Hu,Yongheng Gao,Qisheng Tang,Zhining Zhao,Wenjin Xi,Fan Yang,Wei Zhang,Yue Song,Bin Song,Tao Wang,He Wang |
|
| Aging. 2019; 11(22): 10644 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 66 |
Long non-coding RNA CRNDE promote the progression of tongue squamous cell carcinoma through regulating the PI3K/AKT/mTOR signaling pathway |
|
|
| Zhongheng Yang,Weizhi Chen |
|
| RSC Advances. 2019; 9(37): 21381 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 67 |
ABT-737 and erufosine combination against castration-resistant prostate cancer |
|
|
| Ezgi Avsar Abdik,Ferda Kaleagasioglu,Hüseyin Abdik,Fikrettin Sahin,Martin R. Berger |
|
| Anti-Cancer Drugs. 2019; 30(4): 383 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 68 |
An AR-ERG transcriptional signature defined by long-range chromatin interactomes in prostate cancer cells |
|
|
| Zhizhuo Zhang,Kern Rei Chng,Shreyas Lingadahalli,Zikai Chen,Mei Hui Liu,Huy Hoang Do,Shaojiang Cai,Nicola Rinaldi,Huay Mei Poh,Guoliang Li,Ying Ying Sung,Charlie L. Heng,Leighton J. Core,Si Kee Tan,Xiaoan Ruan,John T. Lis,Manolis Kellis,Yijun Ruan,Wing-Kin Sung,Edwin Cheung |
|
| Genome Research. 2019; 29(2): 223 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 69 |
DEPTOR is an in vivo tumor suppressor that inhibits prostate tumorigenesis via the inactivation of mTORC1/2 signals |
|
|
| Xiaoyu Chen,Xiufang Xiong,Danrui Cui,Fei Yang,Dongping Wei,Haomin Li,Jianfeng Shu,Yanli Bi,Xiaoqing Dai,Longyuan Gong,Yi Sun,Yongchao Zhao |
|
| Oncogene. 2019; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 70 |
CircLMTK2 acts as a tumor suppressor in prostate cancer via regulating the expression of microRNA-183 |
|
|
| Chengjun Jin,Weiming Zhao,Zijian Zhang,Wanpeng Liu |
|
| Life Sciences. 2019; : 117097 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 71 |
Enhancement of anticancer activity of docetaxel by combination with Fuzheng Yiliu decoction in a mouse model of castration-resistant prostate cancer |
|
|
| Wei Fu,Zhiming Hong,Xujun You,Jing Din,Baishu Chen,Beibei Zhao,Gengyan Yuan,Qixin Li |
|
| Biomedicine & Pharmacotherapy. 2019; 118: 109374 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 72 |
Silencing of RHEB inhibits cell proliferation and promotes apoptosis in colorectal cancer cells via inhibition of the mTOR signaling pathway |
|
|
| Yuxi Tian,Liangfang Shen,Fujun Li,Junwen Yang,Xiaoping Wan,Miao Ouyang |
|
| Journal of Cellular Physiology. 2019; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 73 |
ING5 inhibits cancer aggressiveness by inhibiting Akt and activating p53 in prostate cancer |
|
|
| Neslisah Barlak,Ozel Capik,Fatma Sanli,Ahsen Kilic,Abdulmelik Aytatli,Aysenur Yazici,Serkan Ortucu,Michael Ittmann,Omer Faruk Karatas |
|
| Cell Biology International. 2019; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 74 |
Phase I study of ipatasertib as a single agent and in combination with abiraterone plus prednisolone in Japanese patients with advanced solid tumors |
|
|
| Toshihiko Doi,Yutaka Fujiwara,Nobuaki Matsubara,Junichi Tomomatsu,Satoru Iwasa,Akari Tanaka,Chihiro Endo-Tsukude,Shintaro Nakagawa,Shunji Takahashi |
|
| Cancer Chemotherapy and Pharmacology. 2019; 84(2): 393 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 75 |
Cross-talk between ribosome biogenesis, translation, and mTOR in CD133+?4/CD44+?prostate cancer stem cells |
|
|
| Z. Binal,E. Açikgöz,F. Kizilay,G. Öktem,B. Altay |
|
| Clinical and Translational Oncology. 2019; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 76 |
miR-122 and miR-199 synergistically promote autophagy in?oral lichen planus by targeting the Akt/mTOR pathway |
|
|
| Liang Wang,Wei Wu,Jijun Chen,Youhua Li,Ming Xu,Yawei Cai |
|
| International Journal of Molecular Medicine. 2019; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 77 |
Combinatorial Effect of Abiraterone Acetate and NVP-BEZ235 on Prostate Tumor Progression in Rats |
|
|
| Bianca Facchim Gonçalves,Silvana Gisele Pegorin de Campos,Wagner José Fávaro,Joyce Zalotti Brandt,Cristiane Figueiredo Pinho,Luis Antônio Justulin,Sebastião Roberto Taboga,Wellerson Rodrigo Scarano |
|
| Hormones and Cancer. 2018; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 78 |
Taxane resistance in castration-resistant prostate cancer: mechanisms and therapeutic strategies |
|
|
| Brandon Bumbaca,Wei Li |
|
| Acta Pharmaceutica Sinica B. 2018; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 79 |
PI3K pathway in prostate cancer: All resistant roads lead to PI3K |
|
|
| Soonbum Park,Young Sik Kim,Davis Yeon Kim,Insuk So,Ju-Hong Jeon |
|
| Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2018; 1870(2): 198 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 80 |
Influence and mechanism of Angiotensin 1-7 on biological properties of normal prostate epithelial cells |
|
|
| Kamila Dominska,Piotr Okla,Karolina Kowalska,Dominika Ewa Habrowska-Górczynska,Kinga Anna Urbanek,Tomasz Ochedalski,Agnieszka Wanda Piastowska-Ciesielska |
|
| Biochemical and Biophysical Research Communications. 2018; 502(1): 152 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 81 |
Elevated phospholipase D activity in androgen-insensitive prostate cancer cells promotes both survival and metastatic phenotypes |
|
|
| Matthew Utter,Sohag Chakraborty,Limor Goren,Lucas Feuser,Yuan-Shan Zhu,David A. Foster |
|
| Cancer Letters. 2018; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 82 |
Targeting AR-Beclin 1 Complex-Modulated Growth Factor Signaling Increases the Antiandrogen-Enzalutamide Sensitivity to Better Suppress the Castration-Resistant Prostate Cancer Growth |
|
|
| Meng Zhang,Yin Sun,Jialin Meng,Li Zhang,Chaozhao Liang,Chawnshang Chang |
|
| Cancer Letters. 2018; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 83 |
A phase II study of the dual mTOR inhibitor MLN0128 in patients with metastatic castration resistant prostate cancer |
|
|
| Laura Graham,Kalyan Banda,Alba Torres,Brett S. Carver,Yu Chen,Katie Pisano,Greg Shelkey,Tracy Curley,Howard I. Scher,Tamara L. Lotan,Andrew C. Hsieh,Dana E. Rathkopf |
|
| Investigational New Drugs. 2018; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 84 |
Androgen receptor: what we know and what we expect in castration-resistant prostate cancer |
|
|
| Zhonglin Cai,Weijie Chen,Jianzhong Zhang,Hongjun Li |
|
| International Urology and Nephrology. 2018; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 85 |
NPRL2 enhances autophagy and the resistance to Everolimus in castration-resistant prostate cancer |
|
|
| Zhixiong Chen,Qilong Jiang,Pingyu Zhu,Yanlin Chen,Xuemei Xie,Zhongbo Du,Li Jiang,Wei Tang |
|
| The Prostate. 2018; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 86 |
A natural molecule, urolithin A, downregulates androgen receptor activation and suppresses growth of prostate cancer |
|
|
| Nisha R. Dahiya,Balaji Chandrasekaran,Venkatesh Kolluru,Murali Ankem,Chendil Damodaran,Manicka V. Vadhanam |
|
| Molecular Carcinogenesis. 2018; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 87 |
MiR-93 functions as a tumor promoter in prostate cancer by targeting disabled homolog 2 (DAB2) and an antitumor polysaccharide from green tea (Camellia sinensis) on their expression |
|
|
| Ke Yang,Yuan-Wei Li,Zhi-Yong Gao,Wei Xiao,Tie-Qiu Li,Wei Song,Jue Zheng,Hao Chen,Gui-Heng Chen,Hao-Yu Zou |
|
| International Journal of Biological Macromolecules. 2018; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 88 |
Systems pharmacology using mass spectrometry identifies critical response nodes in prostate cancer |
|
|
| H. Alexander Ebhardt,Alex Root,Yansheng Liu,Nicholas Paul Gauthier,Chris Sander,Ruedi Aebersold |
|
| npj Systems Biology and Applications. 2018; 4(1) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 89 |
Clinical implications of PTEN loss in prostate cancer |
|
|
| Tamara Jamaspishvili,David M. Berman,Ashley E. Ross,Howard I. Scher,Angelo M. De Marzo,Jeremy A. Squire,Tamara L. Lotan |
|
| Nature Reviews Urology. 2018; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 90 |
Phenethyl isothiocyanate in combination with dibenzoylmethane inhibits the androgen-independent growth of prostate cancer cells |
|
|
| Huarong Huang,Yan He,Lanyue Zhang,Hongping Xiang,Dongli Li,Wenfeng Liu,Xue-Tao Xu,Susan Goodin,Kun Zhang,Xi Zheng |
|
| Food & Function. 2018; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 91 |
A unifying biology of sex steroid-induced apoptosis in prostate and breast cancers |
|
|
| Philipp Y Maximov,Balkees Abderrahman,Ramona F Curpan,Yousef M Hawsawi,Ping Fan,V Craig Jordan |
|
| Endocrine-Related Cancer. 2018; 25(2): R83 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 92 |
Interaction between 3-Bromopyruvate and SC-514 in prostate cancer treatment |
|
|
| Toluleke Oloruntobi Famuyiwa,Joubin Jebelli,James Kwasi Kumi Diaka,Waseem Asghar |
|
| Journal of Cancer Prevention & Current Research. 2018; 9(6) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 93 |
T-cell lymphomas associated gene expression signature: Bioinformatics analysis based on gene expression Omnibus |
|
|
| Lei-lei Zhou,Xiao-yue Xu,Jie Ni,Xia Zhao,Jian-wei Zhou,Ji-feng Feng |
|
| European Journal of Haematology. 2018; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 94 |
Targeted AKT Inhibition in Prostate Cancer Cells and Spheroids Reduces Aerobic Glycolysis and Generation of Hyperpolarized [1-13C] Lactate |
|
|
| Sui Seng Tee,Izabela Suster,Steven Truong,Sangmoo Jeong,Roozbeh Eskandari,Valentina DiGialleonardo,Julio A. Alvarez,Hannah N. Aldeborgh,Kayvan R. Keshari |
|
| Molecular Cancer Research. 2018; 16(3): 453 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 95 |
Prognostic and histogenetic roles of gene alteration and the expression of key potentially actionable targets in salivary duct carcinomas |
|
|
| Tomotaka Shimura,Yuichiro Tada,Hideaki Hirai,Daisuke Kawakita,Satoshi Kano,Kiyoaki Tsukahara,Akira Shimizu,Soichiro Takase,Yorihisa Imanishi,Hiroyuki Ozawa,Kenji Okami,Yuichiro Sato,Yukiko Sato,Chihiro Fushimi,Hideaki Takahashi,Takuro Okada,Hiroki Sato,Kuninori Otsuka,Yoshihiro Watanabe,Akihiro Sakai,Koji Ebisumoto,Takafumi Togashi,Yushi Ueki,Hisayuki Ota,Mizuo Ando,Shinji Kohsaka,Toyoyuki Hanazawa,Hideaki Chazono,Yoshiyuki Kadokura,Hitome Kobayashi,Toshitaka Nagao |
|
| Oncotarget. 2018; 9(2): 1852 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 96 |
A Systems-Level Analysis of Mechanisms of Platycodon grandiflorum Based on A Network Pharmacological Approach |
|
|
| Musun Park,Sa-Yoon Park,Hae-Jeung Lee,Chang-Eop Kim |
|
| Molecules. 2018; 23(11): 2841 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 97 |
miR-202 suppresses prostate cancer growth and metastasis by targeting PIK3CA |
|
|
| Shengping Zhang,Jiarong Cai,Wenjun Xie,Hui Luo,Fei Yang |
|
| Experimental and Therapeutic Medicine. 2018; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 98 |
AR Signaling and the PI3K Pathway in Prostate Cancer |
|
|
| Megan Crumbaker,Leila Khoja,Anthony Joshua |
|
| Cancers. 2017; 9(4): 34 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 99 |
A Phase I Study of Abiraterone Acetate Combined with BEZ235, a Dual PI3K/mTOR Inhibitor, in Metastatic Castration Resistant Prostate Cancer |
|
|
| Xiao X. Wei,Andrew C. Hsieh,Won Kim,Terence Friedlander,Amy M. Lin,Mirela Louttit,Charles J. Ryan |
|
| The Oncologist. 2017; 22(5): 503 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 100 |
Clinicopathological signature of p21-activated kinase 1 in prostate cancer and its regulation of proliferation and autophagy via the mTOR signaling pathway |
|
|
| Zhanyu Wang,Guojin Jia,Yan Li,Jikai Liu,Jinfang Luo,Jihong Zhang,Guoxiong Xu,Gang Chen |
|
| Oncotarget. 2017; 8(14): 22563 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 101 |
Itraconazole exerts its anti-melanoma effect by suppressing Hedgehog, Wnt, and PI3K/mTOR signaling pathways |
|
|
| Guanzhao Liang,Musang Liu,Qiong Wang,Yongnian Shen,Huan Mei,Dongmei Li,Weida Liu |
|
| Oncotarget. 2017; 8(17): 28510 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 102 |
Pharmacological treatment with inhibitors of nuclear export enhances the antitumor activity of docetaxel in human prostate cancer |
|
|
| Giovanni Luca Gravina,Andrea Mancini,Alessandro Colapietro,Francesco Marampon,Roberta Sferra,Simona Pompili,Leda Assunta Biordi,Roberto Iorio,Vincenzo Flati,Christian Argueta,Yosef Landesman,Michael Kauffman,Sharon Shacham,Claudio Festuccia |
|
| Oncotarget. 2017; 8(67): 111225 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 103 |
Investigational serine/threonine kinase inhibitors against prostate cancer metastases |
|
|
| Claudio Festuccia |
|
| Expert Opinion on Investigational Drugs. 2017; 26(1): 25 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 104 |
Protein kinase B |
|
|
| Bhumika Wadhwa,Ubaid Makhdoomi,Ram Vishwakarma,Fayaz Malik |
|
| Anti-Cancer Drugs. 2017; 28(6): 569 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 105 |
The androgen receptor is a negative regulator of eIF4E phosphorylation at S209: implications for the use of mTOR inhibitors in advanced prostate cancer |
|
|
| L S DæAbronzo,S Bose,M E Crapuchettes,R E Beggs,R L Vinall,C G Tepper,S Siddiqui,M Mudryj,F U Melgoza,B P Durbin-Johnson,R W deVere White,P M Ghosh |
|
| Oncogene. 2017; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 106 |
Anti-androgen 2-hydroxyflutamide modulates cadherin, catenin and androgen receptor phosphorylation in androgen-sensitive LNCaP and androgen-independent PC3 prostate cancer cell lines acting via PI3K/Akt and MAPK/ERK1/2 pathways |
|
|
| Ewelina Górowska-Wójtowicz,Anna Hejmej,Alicja Kaminska,Laura Pardyak,Malgorzata Kotula-Balak,Joanna Dulinska-Litewka,Piotr Laidler,Barbara Bilinska |
|
| Toxicology in Vitro. 2017; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 107 |
mTOR in Down syndrome: Role in Aß and tau neuropathology and transition to Alzheimer disease-like dementia |
|
|
| Fabio Di Domenico,Antonella Tramutola,Cesira Foppoli,Elizabeth Head,Marzia Perluigi,D. Allan Butterfield |
|
| Free Radical Biology and Medicine. 2017; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 108 |
Acne vulgaris: the metabolic syndrome of the pilo-sebaceous follicle |
|
|
| Bodo C. Melnik |
|
| Clinics in Dermatology. 2017; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 109 |
PTEN loss and activation of K-RAS and ß-catenin cooperate to accelerate prostate tumourigenesis |
|
|
| Matthew T Jefferies,Adam C Cox,Boris Y Shorning,Valerie Meniel,David Griffiths,Howard G Kynaston,Matthew J Smalley,Alan R Clarke |
|
| The Journal of Pathology. 2017; 243(4): 442 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 110 |
Isorhapontigenin induced cell growth inhibition and apoptosis by targeting EGFR-related pathways in prostate cancer |
|
|
| Cuicui Zhu,Qingyi Zhu,Zhaomeng Wu,Yingying Yin,Dan Kang,Shan Lu,Ping Liu |
|
| Journal of Cellular Physiology. 2017; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 111 |
Mechanisms of Therapeutic Resistance in Prostate Cancer |
|
|
| Mary Nakazawa,Channing Paller,Natasha Kyprianou |
|
| Current Oncology Reports. 2017; 19(2) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 112 |
miR-1307 promotes the proliferation of prostate cancer by targeting FOXO3A |
|
|
| Xiaodi Qiu,Ying Dou |
|
| Biomedicine & Pharmacotherapy. 2017; 88: 430 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 113 |
MiR-129 inhibits cell proliferation and metastasis by targeting ETS1 via PI3K/AKT/mTOR pathway in prostate cancer |
|
|
| Song Xu,Jingping Ge,Zhengyu Zhang,Wenquan Zhou |
|
| Biomedicine & Pharmacotherapy. 2017; 96: 634 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 114 |
MiR-1271 Inhibits Cell Growth in Prostate Cancer by Targeting ERG |
|
|
| Miao Wang,Wei Gao,Dehong Lu,Lianghong Teng |
|
| Pathology & Oncology Research. 2017; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 115 |
SU6668 modulates prostate cancer progression by downregulating MTDH/AKT signaling pathway |
|
|
| Benjiang Qian,Yi Yao,Changming Liu,Jiabing Zhang,Huihong Chen,Huizhang Li |
|
| International Journal of Oncology. 2017; 50(5): 1601 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 116 |
IL-8 promotes proliferation and inhibition of apoptosis via STAT3/AKT/NF-?B pathway in prostate cancer |
|
|
| Yidi Guo,Ying Zang,Lianzheng Lv,Feng Cai,Tingting Qian,Guoying Zhang,Quancheng Feng |
|
| Molecular Medicine Reports. 2017; 16(6): 9035 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 117 |
Synergistic effects of phenylhexyl isothiocyanate and LY294002 on the PI3K/Akt signaling pathway in HL-60 cells |
|
|
| Huicong Yang,Yiqun Huang,Yong Zou,Xudong Ma |
|
| Oncology Letters. 2017; 14(3): 3043 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 118 |
Phosphorylated mTOR is associated to androgen receptor expression in early triple-negative breast cancer |
|
|
| M. Pistelli,Z. Ballatore,A. Santinelli,T. Biscotti,F. Piva,G. Occhipinti,A. Della Mora,A. Pagliacci,N. Battelli,L. Bastianelli,M. De lisa,R. Bracci,E. Maccaroni,R. Berardi,S. Cascinu |
|
| Oncology Reports. 2016; 36(2): 755 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 119 |
Androgen-induced miR-27A acted as a tumor suppressor by targeting MAP2K4 and mediated prostate cancer progression |
|
|
| Xuechao Wan,Wenhua Huang,Shu Yang,Yalong Zhang,Pu Zhang,Zhe Kong,Tao Li,Hai Wu,Fengxiang Jing,Yao Li |
|
| The International Journal of Biochemistry & Cell Biology. 2016; 79: 249 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 120 |
Role of corticosteroids in prostate cancer progression: implications for treatment strategy in metastatic castration-resistant patients |
|
|
| S. Sideris,F. Aoun,C. N. Martinez,S. Latifyan,A. Awada,G. Costante,T. Gil |
|
| Journal of Endocrinological Investigation. 2016; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 121 |
mTOR Inhibitors in Castration-Resistant Prostate Cancer: A Systematic Review |
|
|
| Cara M. Statz,Sara E. Patterson,Susan M. Mockus |
|
| Targeted Oncology. 2016; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 122 |
Discovery of 4-(Piperazin-1-yl)-7H-pyrrolo[2,3-d]pyrimidine Derivatives as Akt Inhibitors |
|
|
| Yang Liu,Yanzhen Yin,Jingya Zhang,Krystle Nomie,Liang Zhang,Dezhi Yang,Michael L. Wang,Guisen Zhao |
|
| Archiv der Pharmazie. 2016; : n/a |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 123 |
Determination of MLN0128, an investigational antineoplastic agent, in human plasma by LC-MS/MS |
|
|
| Sandeep R. Kunati,Yan Xu |
|
| Biomedical Chromatography. 2016; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 124 |
Amygdalin delays cell cycle progression and blocks growth of prostate cancer cells in vitro |
|
|
| Jasmina Makarevic,Igor Tsaur,Eva Juengel,Hendrik Borgmann,Karen Nelson,Christian Thomas,Georg Bartsch,Axel Haferkamp,Roman A. Blaheta |
|
| Life Sciences. 2016; 147: 137 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 125 |
The cannabinoid WIN 55,212-2 prevents neuroendocrine differentiation of LNCaP prostate cancer cells |
|
|
| C Morell,A Bort,D Vara,A Ramos-Torres,N Rodríguez-Henche,I Díaz-Laviada |
|
| Prostate Cancer and Prostatic Diseases. 2016; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 126 |
Nimbolide, a neem limonoid inhibits Phosphatidyl Inositol-3 Kinase to activate Glycogen Synthase Kinase-3ß in a hamster model of oral oncogenesis |
|
|
| Josephraj Sophia,Kranthi Kiran Kishore T.,Jaganathan Kowshik,Rajakishore Mishra,Siddavaram Nagini |
|
| Scientific Reports. 2016; 6: 22192 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 127 |
MiR-4638-5p inhibits castration resistance of prostate cancer through repressing Kidins220 expression and PI3K/AKT pathway activity |
|
|
| Yang Wang,Ning Shao,Xueying Mao,Minmin Zhu,Weifei Fan,Zhixiang Shen,Rong Xiao,Chuncai Wang,Wenping Bao,Xinyu Xu,Chun Yang,Jian Dong,Deshui Yu,Yan Wu,Caixia Zhu,Liting Wen,Xiaojie Lu,Yong-Jie Lu,Ninghan Feng |
|
| Oncotarget. 2016; 7(30): 47444 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 128 |
The anti-cancer activity of the mTORC1/2 dual inhibitor XL388 in preclinical osteosarcoma models |
|
|
| Yun-Rong Zhu,Xiao-zhong Zhou,Lun-qing Zhu,Chen Yao,Jian-Feng Fang,Feng Zhou,Xiong-Wei Deng,Yun-Qing Zhang |
|
| Oncotarget. 2016; 7(31): 49527 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 129 |
Decreased TSPAN1 promotes prostate cancer progression and is a marker for early biochemical recurrence after radical prostatectomy |
|
|
| Fan Xu,Yujing Gao,Yanqing Wang,Jiahua Pan,Jianjun Sha,Xiaoguang Shao,Xunlei Kang,Jun Qin,M. James You,Yiran Huang,Baijun Dong,Wei Xue |
|
| Oncotarget. 2016; 7(39): 63294 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 130 |
Inhibition of the PI3K/AKT/mTOR Pathway in Solid Tumors |
|
|
| Patricia Mucci LoRusso |
|
| Journal of Clinical Oncology. 2016; 34(31): 3803 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 131 |
Cotargeting Androgen Receptor Splice Variants and mTOR Signaling Pathway for the Treatment of Castration-Resistant Prostate Cancer |
|
|
| Minoru Kato,Carmen A. Banuelos,Yusuke Imamura,Jacky K. Leung,Daniel P. Caley,Jun Wang,Nasrin R. Mawji,Marianne D. Sadar |
|
| Clinical Cancer Research. 2016; 22(11): 2744 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 132 |
Effects of Brassicaceae Isothiocyanates on Prostate Cancer |
|
|
| Silvia Novío,María Cartea,Pilar Soengas,Manuel Freire-Garabal,María Núñez-Iglesias |
|
| Molecules. 2016; 21(5): 626 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 133 |
mTOR pathway activation is a favorable prognostic factor in human prostate adenocarcinoma |
|
|
| Suzan Stelloo,Joyce Sanders,Ekaterina Nevedomskaya,Jeroen de Jong,Dennis Peters,Geert J.L.H. van Leenders,Guido Jenster,Andries M. Bergman,Wilbert Zwart |
|
| Oncotarget. 2016; 7(22): 32916 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 134 |
Androgen-induced miR-135a acts as a tumor suppressor through downregulating RBAK and MMP11, and mediates resistance to androgen deprivation therapy |
|
|
| Xuechao Wan,Honglei Pu,Wenhua Huang,Shu Yang,Yalong Zhang,Zhe Kong,Zhuoran Yang,Peiqing Zhao,Ao Li,Tao Li,Yao Li |
|
| Oncotarget. 2016; 7(32): 51284 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 135 |
Identification of the epigenetic reader CBX2 as a potential drug target in advanced prostate cancer |
|
|
| Pier-Luc Clermont,Francesco Crea,Yan Ting Chiang,Dong Lin,Amy Zhang,James Z. L. Wang,Abhijit Parolia,Rebecca Wu,Hui Xue,Yuwei Wang,Jiarui Ding,Kelsie L. Thu,Wan L. Lam,Sohrab P. Shah,Colin C. Collins,Yuzhuo Wang,Cheryl D. Helgason |
|
| Clinical Epigenetics. 2016; 8(1) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 136 |
ACSL4 promotes prostate cancer growth, invasion and hormonal resistance |
|
|
| Xinyu Wu,Fangming Deng,Yirong Li,Garrett Daniels,Xinxin Du,Qinghu Ren,Jinhua Wang,Ling Hang Wang,Yang Yang,Valerio Zhang,David Zhang,Fei Ye,Jonathan Melamed,Marie E. Monaco,Peng Lee |
|
| Oncotarget. 2015; 6(42): 44849 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 137 |
Milk—A Nutrient System of Mammalian Evolution Promoting mTORC1-Dependent Translation |
|
|
| Bodo Melnik |
|
| International Journal of Molecular Sciences. 2015; 16(8): 17048 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 138 |
Non-Coding RNAs in Castration-Resistant Prostate Cancer: Regulation of Androgen Receptor Signaling and Cancer Metabolism |
|
|
| Jing-Wen Shih,Ling-Yu Wang,Chiu-Lien Hung,Hsing-Jien Kung,Chia-Ling Hsieh |
|
| International Journal of Molecular Sciences. 2015; 16(12): 28943 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 139 |
The HDL receptor SR-BI is associated with human prostate cancer progression and plays a possible role in establishing androgen independence |
|
|
| David Schörghofer,Katharina Kinslechner,Andrea Preitschopf,Birgit Schütz,Clemens Röhrl,Markus Hengstschläger,Herbert Stangl,Mario Mikula |
|
| Reproductive Biology and Endocrinology. 2015; 13(1) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 140 |
Transcription factor and microRNA-regulated network motifs for cancer and signal transduction networks |
|
|
| Wen-Tsong Hsieh,Ke-Rung Tzeng,Jin-Shuei Ciou,Jeffrey JP Tsai,Nilubon Kurubanjerdjit,Chien-Hung Huang,Ka-Lok Ng |
|
| BMC Systems Biology. 2015; 9(Suppl 1): S5 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 141 |
Cell type-specific abundance of 4EBP1 primes prostate cancer sensitivity or resistance to PI3K pathway inhibitors |
|
|
| A. C. Hsieh,H. G. Nguyen,L. Wen,M. P. Edlind,P. R. Carroll,W. Kim,D. Ruggero |
|
| Science Signaling. 2015; 8(403): ra116 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 142 |
miR-195 Inhibits Tumor Progression by Targeting RPS6KB1 in Human Prostate Cancer |
|
|
| Chao Cai,Qing-Biao Chen,Zhao-Dong Han,Yan-Qiong Zhang,Hui-Chan He,Jia-Hong Chen,Yan-Ru Chen,Sheng-Bang Yang,Yong-Ding Wu,Yan-Ru Zeng,Guo-Qiang Qin,Yu-Xiang Liang,Qi-Shan Dai,Fu-Neng Jiang,Shu-lin Wu,Guo-Hua Zeng,Wei-De Zhong,Chin-Lee Wu |
|
| Clinical Cancer Research. 2015; 21(21): 4922 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 143 |
Persistent androgen receptor addiction in castration-resistant prostate cancer |
|
|
| Michael T. Schweizer,Evan Y. Yu |
|
| Journal of Hematology & Oncology. 2015; 8(1) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 144 |
Novel Cancer Chemotherapy Hits by Molecular Topology: Dual Akt and Beta-Catenin Inhibitors |
|
|
| Riccardo Zanni,Maria Galvez-Llompart,Cecilia Morell,Nieves Rodríguez-Henche,Inés Díaz-Laviada,Maria Carmen Recio-Iglesias,Ramon Garcia-Domenech,Jorge Galvez,Yuan-Soon Ho |
|
| PLOS ONE. 2015; 10(4): e0124244 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 145 |
VS-5584, a Novel PI3K-mTOR Dual Inhibitor, Inhibits Melanoma Cell Growth In Vitro and In Vivo |
|
|
| Zheren Shao,Qi Bao,Fangzhen Jiang,Huan Qian,Quan Fang,Xueqing Hu,Cong Cao |
|
| PLOS ONE. 2015; 10(7): e0132655 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 146 |
Derivatives containing both coumarin and benzimidazole potently induce caspase-dependent apoptosis of cancer cells through inhibition of PI3K-AKT-mTOR signaling |
|
|
| Haitao Liu,Yubin Wang,Ashok Sharma,Rui Mao,Na Jiang,Boying Dun,Jin-Xiong She |
|
| Anti-Cancer Drugs. 2015; : 1 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 147 |
An open label randomized phase II study of pasireotide with or without everolimus in castrate-resistant chemotherapy-naïve prostate cancer patients |
|
|
| Jianqing Lin,Aileen Deng,Jean Hoffman-Censits,Geoffrey Gibney,Terry Hyslop,Brooke Miller,Deborah Kilpatrick,Serge Jabbour,William Kevin Kelly |
|
| Cancer Treatment Communications. 2015; 4: 192 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 148 |
PI3K/Akt signaling in osteosarcoma |
|
|
| Jian Zhang,Xiao-Hua Yu,Yi-Guo Yan,Cheng Wang,Wen-Jun Wang |
|
| Clinica Chimica Acta. 2015; 444: 182 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 149 |
Dual targeting of mTORC1 and mTORC2 by INK-128 potently inhibits human prostate cancer cell growth in vitro and in vivo |
|
|
| Shang-jun Jiang,Shuo Wang |
|
| Tumor Biology. 2015; 36(10): 8177 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 150 |
HOXA1 enhances the cell proliferation, invasion and metastasis of prostate cancer cells |
|
|
| Haitao Wang,Guanzhong Liu,Dan Shen,Huamao Ye,Jinming Huang,Li Jiao,Yinghao Sun |
|
| Oncology Reports. 2015; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 151 |
PIP5K1 inhibition as a therapeutic strategy for prostate cancer |
|
|
| J. M. Drake,J. Huang |
|
| Proceedings of the National Academy of Sciences. 2014; 111(35): 12578 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
